Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Orthop. Jul 18, 2013; 4(3): 114-119
Published online Jul 18, 2013. doi: 10.5312/wjo.v4.i3.114
Published online Jul 18, 2013. doi: 10.5312/wjo.v4.i3.114
Orthopaedic perspective on bone metastasis
Alan P Molloy, Gary C O’Toole, Department of Orthopaedic Oncology, St Vincents Hospital, Dublin 4, Ireland
Author contributions: Molloy AP contributed to data review, drafting of paper; O’Toole GC was the consultant supervisor, contributed to review and approval of paper.
Correspondence to: Gary C O’Toole, MD, Department of Orthopaedic Oncology, St Vincents Hospital, Elm Park, Dublin 4, Ireland. alanpmolloy@yahoo.com
Telephone: +353-1221-4000 Fax: +353-1277-4190
Received: October 31, 2012
Revised: May 21, 2013
Accepted: June 5, 2013
Published online: July 18, 2013
Processing time: 260 Days and 19.8 Hours
Revised: May 21, 2013
Accepted: June 5, 2013
Published online: July 18, 2013
Processing time: 260 Days and 19.8 Hours
Core Tip
Core tip: This paper discusses the pathophysiology and patient implications of bone metastasis. We aim to describe the orthopaedic input into the management of this condition, especially in a multi-disciplinary setting. We believe that orthopaedics do not have a significant enough involvement in the treatment of long bone metastasis, although from this paper we feel we have many options to offer. The future of metastasis treatment may be targeted at the molecular level but current management options do require an understanding of musculoskeletal oncology to obtain best patient outcomes through operative and non-operative means.